Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

This study is not yet open for participant recruitment.

Verified by University of California, Los Angeles, May 2006

Sponsored by:	University of California, Los Angeles
Information provided by:	University of California, Los Angeles
ClinicalTrials.gov Identifier:	NCT00351728

Purpose

Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT scans of the whole body are performed at baseline, three months later, and six months after that for a total of three combined scans in the first year. Subsequently, these combined scans will be performed at 6-monthly intervals for a total of two combined scans per year.

Condition
Ocular Melanoma Choroidal Melanoma Uveal Melanoma

MedlinePlus related topics: Melanoma Nuclear Scans

U.S. FDA Resources

Study Type:	Observational
Study Design:	Longitudinal, Defined Population, Prospective Study

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or the part of the eye behind the iris).
Patients 18 years of age or older.
Patients able to give informed consent.

Exclusion Criteria:

Patients who refuse to participate in the study.
Patients who are unable to cooperate with or cannot undergo PET/CT scanning.
Patients who will be moving out of the area of UCLA during the ten years of this study.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00351728

Sponsors and Collaborators

University of California, Los Angeles

Investigators

Principal Investigator:

Tara A Young, MD, PhD

Jules Stein Eye Institute, UCLA

More Information

Study ID Numbers:	UCLA IRB #05-04-016
Study First Received:	July 12, 2006
Last Updated:	July 12, 2006
ClinicalTrials.gov Identifier:	NCT00351728
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Ocular melanoma
Neuroectodermal Tumors
Uveal melanoma
Intraocular melanoma
Nevus, Pigmented
Neoplasms, Germ Cell and Embryonal

Neoplasm Metastasis
Neuroepithelioma
Nevus
Melanoma of the choroid
Neuroendocrine Tumors
Melanoma

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Nevi and Melanomas

ClinicalTrials.gov processed this record on January 14, 2009